• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

登革热感染后急性后遗症负担的不确定性。

The Uncertainty Surrounding the Burden of Post-acute Consequences of Dengue Infection.

机构信息

Oxford University Clinical Research Unit, Wellcome Africa Asia Programme, Ho Chi Minh City, Vietnam.

Oxford University Clinical Research Unit, Wellcome Africa Asia Programme, Ho Chi Minh City, Vietnam; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

出版信息

Trends Parasitol. 2019 Sep;35(9):673-676. doi: 10.1016/j.pt.2019.06.004. Epub 2019 Jul 3.

DOI:10.1016/j.pt.2019.06.004
PMID:31279656
Abstract

Post-acute consequences currently form a significant component of the dengue disability-adjusted life year (DALY) burden estimates. However, there is considerable uncertainty regarding the incidence, duration, and severity of these symptoms. Further research is needed to more accurately estimate the health and economic burden of these dengue manifestations.

摘要

急性后后果目前是登革热残疾调整生命年(DALY)负担估计的重要组成部分。然而,这些症状的发病率、持续时间和严重程度存在相当大的不确定性。需要进一步研究,以更准确地估计这些登革热表现的健康和经济负担。

相似文献

1
The Uncertainty Surrounding the Burden of Post-acute Consequences of Dengue Infection.登革热感染后急性后遗症负担的不确定性。
Trends Parasitol. 2019 Sep;35(9):673-676. doi: 10.1016/j.pt.2019.06.004. Epub 2019 Jul 3.
2
Impact of a Nonfatal Dengue Episode on Disability-Adjusted Life Years: A Systematic Analysis.非重症登革热发病对伤残调整生命年的影响:系统分析。
Am J Trop Med Hyg. 2018 Dec;99(6):1458-1465. doi: 10.4269/ajtmh.18-0309.
3
Economic cost and burden of dengue during epidemics and non-epidemic years in Taiwan.台湾登革热流行和非流行年份的经济成本和负担。
J Infect Public Health. 2018 Mar-Apr;11(2):215-223. doi: 10.1016/j.jiph.2017.07.021. Epub 2017 Jul 27.
4
Cost and disease burden of dengue in Cambodia.柬埔寨登革热的成本和疾病负担。
BMC Public Health. 2010 Aug 31;10:521. doi: 10.1186/1471-2458-10-521.
5
Persistent Symptoms of Dengue: Estimates of the Incremental Disease and Economic Burden in Mexico.登革热的持续症状:墨西哥新增疾病及经济负担评估
Am J Trop Med Hyg. 2016 May 4;94(5):1085-1089. doi: 10.4269/ajtmh.15-0896. Epub 2016 Mar 14.
6
The Estimates of the Health and Economic Burden of Dengue in Vietnam.越南登革热的健康和经济负担估计。
Trends Parasitol. 2018 Oct;34(10):904-918. doi: 10.1016/j.pt.2018.07.007. Epub 2018 Aug 9.
7
Economic cost and burden of dengue in the Philippines.菲律宾登革热的经济成本与负担。
Am J Trop Med Hyg. 2015 Feb;92(2):360-366. doi: 10.4269/ajtmh.14-0139. Epub 2014 Dec 15.
8
Economic burden of dengue illness in India from 2013 to 2016: A systematic analysis.2013 年至 2016 年印度登革热疾病的经济负担:系统分析。
Int J Infect Dis. 2019 Jul;84S:S68-S73. doi: 10.1016/j.ijid.2019.01.010. Epub 2019 Jan 11.
9
The global economic burden of dengue: a systematic analysis.登革热的全球经济负担:系统分析。
Lancet Infect Dis. 2016 Aug;16(8):935-41. doi: 10.1016/S1473-3099(16)00146-8. Epub 2016 Apr 16.
10
Economic burden of dengue in four major cities of Pakistan during 2011.2011年巴基斯坦四个主要城市登革热的经济负担
J Pak Med Assoc. 2015 Mar;65(3):256-9.

引用本文的文献

1
Global prevalence and risk factors of fatigue and post-infectious fatigue among patients with dengue: a systematic review and meta-analysis.登革热患者疲劳及感染后疲劳的全球患病率和危险因素:一项系统评价和荟萃分析
EClinicalMedicine. 2024 Dec 31;80:103041. doi: 10.1016/j.eclinm.2024.103041. eCollection 2025 Feb.
2
The effectiveness of putative wearable repellent technologies to protect against mosquito biting and Aedes-borne diseases, and their economic impact.假定的可穿戴驱蚊技术预防蚊虫叮咬和伊蚊传播疾病的效果及其经济影响。
PLoS Negl Trop Dis. 2024 Dec 18;18(12):e0012621. doi: 10.1371/journal.pntd.0012621. eCollection 2024 Dec.
3
A proposal for further developing fatigue-related post COVID-19 health states for burden of disease studies.
一项关于进一步开发与疲劳相关的新冠后健康状态以用于疾病负担研究的提议。
Arch Public Health. 2023 Nov 2;81(1):193. doi: 10.1186/s13690-023-01212-1.
4
Recovery from Covid-19 critical illness: A secondary analysis of the ISARIC4C CCP-UK cohort study and the RECOVER trial.从新冠肺炎危重症中康复:ISARIC4C CCP-UK队列研究和RECOVER试验的二次分析
J Intensive Care Soc. 2023 May;24(2):162-169. doi: 10.1177/17511437211052226. Epub 2021 Oct 24.
5
An economic evaluation of Wolbachia deployments for dengue control in Vietnam.越南登革热防控中沃尔巴克氏体部署的经济评估
PLoS Negl Trop Dis. 2023 May 30;17(5):e0011356. doi: 10.1371/journal.pntd.0011356. eCollection 2023 May.
6
Is new dengue vaccine efficacy data a relief or cause for concern?新的登革热疫苗效力数据是令人欣慰还是令人担忧?
NPJ Vaccines. 2023 Apr 15;8(1):55. doi: 10.1038/s41541-023-00658-2.
7
Burden of Postinfectious Symptoms after Acute Dengue, Vietnam.越南急性登革热后感染后症状负担
Emerg Infect Dis. 2023 Jan;29(1):160-163. doi: 10.3201/eid2901.220838.
8
Unexplained post-acute infection syndromes.不明原因的急性感染后综合征。
Nat Med. 2022 May;28(5):911-923. doi: 10.1038/s41591-022-01810-6. Epub 2022 May 18.
9
Measuring disability-adjusted life years (DALYs) due to COVID-19 in Scotland, 2020.2020年苏格兰因新型冠状病毒肺炎所致伤残调整生命年的测算
Arch Public Health. 2022 Apr 1;80(1):105. doi: 10.1186/s13690-022-00862-x.
10
A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications.在长新冠/后新冠长期症状中,淀粉样纤维微栓子发挥核心作用:起源和治疗意义。
Biochem J. 2022 Feb 17;479(4):537-559. doi: 10.1042/BCJ20220016.